13D Filing: Baker Bros. Advisors and Acadia Pharmaceuticals Inc (NASDAQ:ACAD)
Baker Bros. Advisors purchased about 1.2 million shares of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) for about $19 per share last week. Here is why the......(read more)
Posts Tagged ‘Baker Bros. Advisors’
Five Stocks To Buy According To Top Biotech-Focused Funds
Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value......(read more)
13D Filing: Baker Bros. Advisors and Genomic Health Inc (GHDX)
Genomic Health Inc (NASDAQ:GHDX): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors......(read more)
13D Filing: Baker Bros. Advisors and Idera Pharmaceuticals Inc. (IDRA)
Idera Pharmaceuticals Inc. (NASDAQ:IDRA): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros......(read more)
13D Filing: Baker Bros. Advisors and Seattle Genetics Inc (SGEN)
Seattle Genetics Inc (NASDAQ:SGEN): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors......(read more)
13D Filing: Baker Bros. Advisors and Beigene Ltd (ADR) (BGNE)
Beigene Ltd (ADR) (BGNE): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors’......(read more)
13D Filing: Baker Bros. Advisors and Mirati Therapeutics Inc. (MRTX)
Mirati Therapeutics Inc. (NASDAQ:MRTX): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros.......(read more)
13D Filing: Baker Bros. Advisors and Erytech Pharma SA (ADR) (ERYP)
Erytech Pharma SA (ADR) (NASDAQ:ERYP): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros. Advisors......(read more)
13D Filing: Baker Bros. Advisors and Idera Pharmaceuticals Inc. (IDRA)
Idera Pharmaceuticals Inc. (NASDAQ:IDRA): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros......(read more)
13D Filing: Baker Bros. Advisors and Acadia Pharmaceuticals Inc (ACAD)
Acadia Pharmaceuticals Inc (NASDAQ:ACAD): Julian Baker And Felix Baker’s Baker Bros. Advisors filed an amended 13D. You can check out Baker Bros......(read more)
13D Filing: Baker Bros. Advisors and Beigene Ltd (ADR) (BGNE)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing SECURITIES AND EXCHANGE COMMISSION......(read more)
13D Filing: Baker Bros. Advisors and Invitae Corp (NVTA)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
13D Filing: Baker Bros. Advisors and Genomic Health Inc (GHDX)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
13D Filing: Baker Bros. Advisors and Acadia Pharmaceuticals Inc (ACAD)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing SECURITIES AND EXCHANGE COMMISSION WASHINGTON......(read more)
13D Filing: Baker Bros. Advisors and Seattle Genetics Inc (SGEN)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE......(read more)
13G Filing: Baker Bros. Advisors and Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing SCHEDULE 13G SECURITIES AND EXCHANGE......(read more)
13D Filing: Baker Bros. Advisors and Bellicum Pharmaceuticals Inc (NASDAQ:BLCM)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 9 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
13D Filing: Baker Bros. Advisors and Aquinox Pharmaceuticals Inc (NASDAQ:AQXP)
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 8 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE......(read more)
The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3
Baker Bros. Advisors has arguably been the most successful healthcare-focused hedge fund on the Street in recent years. Founded by brothers Julian Baker......(read more)
Incyte Corporation (INCY), Seattle Genetics, Inc. (SGEN) & Two More: Top Healthcare Hedge Fund Loves These Stocks
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take......(read more)
Aquinox Pharmaceuticals Inc (AQXP): Baker Bros. Advisors Pushes Stake to Over 45%
A newly-amended 13D filing with the Securities and Exchange Commission revealed that Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) has signed an Underwriting......(read more)
Seattle Genetics Inc (SGEN): Baker Bros. Advisors Raises Stake
Julian and Felix Baker‘s Baker Bros. Advisors reported raising its stake in Seattle Genetics Inc (NASDAQ:SGEN) to 44.35 million common shares,......(read more)
Biocryst Pharmaceuticals Inc (BCRX): Baker Bros. Advisors Unloads Nearly 4 Million Shares
Julian Baker and Felix Baker‘s Baker Bros. Advisors recently filed an amended Form 13D with the SEC to report the sale of common shares of Biocryst......(read more)
Acadia Pharmaceuticals (ACAD): Baker Bros. Advisors Buys More Shares
Julian Baker and Felix Baker, the managers of Baker Bros. Advisors, have taken advantage of Acadia Pharmaceuticals Inc (NASDAQ:ACAD) recently announced......(read more)
Seattle Genetics Inc (SGEN): Baker Bros. Keeps Buying Shares
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors. Among other things......(read more)
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies......(read more)
13D Filing: Baker Bros. Advisors Buys More Shares of Seattle Genetics Inc (SGEN)
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors, by far the......(read more)
Billionaire Christian Leone Boosts Stake in This TV Station Operator, Nelson Peltz Lifts Stake in Struggling Pentair plc. (PNR), Plus 2 Other Moves
Fresh statistics reveal that the 50 most popular stocks among hedge funds lost 10% in 2015, which practically means that individual investors should......(read more)
13D Filing: Baker Bros. Advisors and Beigene, Ltd. (BGNE)
As a new 13D filing with the SEC has revealed, Julian and Felix Bakers‘ Baker Bros. Advisors amassed a substantial position in the recently public......(read more)
13G Filing: Baker Bros. Advisors and Anacor Pharmaceuticals, Inc. (ANAC)
According to a recent filing with the Securities and Exchange Commission, Julian and Felix Bakers‘ Baker Bros. Advisors are bullish on Anacor Pharmaceuticals......(read more)
Bill Gates’ Cascade Investment Boosts AutoNation Inc. (AN) Stake, Buffett Keeps Buying Phillips 66 (PSX), Plus Baker Bros.’ Latest Move
According to statistics from Hedge Fund Research, the average hedge fund lost 2.76% in January, compared to a decline of approximately 5% for the S&......(read more)
Hedge Funds’ Bullish Moves on Aquinox Pharmaceuticals Inc. (AQXP), Herbalife Ltd. (HLF), and Childrens Place Inc. (PLCE)
Most equity investments made by hedge funds are based on strong reasoning and comprehensive analysis, so these investment vehicles do not make blind......(read more)
Billionaire Ubben Cuts Stake in Adobe (ADBE), Carlson Buys More Archrock (AROC), and 2 Other Moves
There are numerous exceptional money managers who have been able to consistently beat broader market benchmarks, which is just one reason why tracking......(read more)
These 4 Stocks Were Just Bought by Baker Bros. Advisors, Clint Carlson, More
The hedge fund industry closed in negative territory for 2015, marking the fourth year of decline for the industry since 1990. Nonetheless, approximately......(read more)
13D Filing: Baker Bros. Advisors Owns 18% of Bellicum Pharmaceuticals, Inc (BLCM)
At Insider Monkey, we closely monitor the moves made by activist investors. Their targets are often undervalued stocks with firm foundations that for......(read more)
A Look At Three Activist Moves By Several Elite Hedge Funds
According to the Schulte, Roth & Zabel’s Activist Investing 2015 Annual Review, 344 companies were targeted by activist investors in 2014, as compared......(read more)
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker......(read more)
Two Healthcare-Focused Funds Buy More Shares Of 2 Promising Companies, While Activist Cashes Out Of IT Company
You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman. Extensive research has concluded......(read more)
Baker Bros. Relentlessly Adding Shares Of One Biotech, Going Activist On Another
Julian Baker and Felix Baker’s Baker Bros. Advisors continues to relentlessly add shares to its position in Seattle Genetics, Inc. (NASDAQ:SGEN). In......(read more)
Don’t Miss White-Hot Baker Bros.’ New Healthcare Picks
At Insider Monkey, we track over 700 hedge funds and investment companies, which allows us to understand the market sentiment towards any given stock.......(read more)
Baker Bros. Advisors Dump 75% Of Stake In XOMA Corp (XOMA) after Late-Stage Study Failure
Was Baker Bros. Advisors‘ investment in XOMA Corp (NASDAQ:XOMA) a mistake? According to a recent filing with the Securities and Exchange Commission......(read more)
Another Score For Baker Bros. As Anacor Pharmaceuticals Inc (ANAC) Soars 65% Premarket On Crisaborole Trial Success
Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) soared to a lofty $140.00 per share pre-market high today, or a whopping 65.47% higher than the stock......(read more)
Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting......(read more)
Baker Bros. Advisors Hits the Jackpot with Pharmacyclics Inc (PCYC) Sale; Incyte Corporation (INCY) Among Fund’s Other Top Picks
Julian Baker and Felix Baker‘s Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015. AbbVie Inc......(read more)
Mirati Therapeutics Inc. (MRTX): Baker Bros. Advisors Increases Stake in Growing Stock
Julian Baker and Felix Baker’s Baker Bros. Advisors recently disclosed an increase of around 929,700 shares to its position in Mirati Therapeutics,......(read more)
Tekmira Pharmaceuticals Corporation (TKMR): Falcon Edge Capital Discloses 10% Passive Stake
Another one of the funds we track here at Insider Monkey has made a big move into Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), as it was revealed......(read more)
Tekmira Pharmaceuticals Corporation (TKMR): RA Capital Management Discloses 10% Passive Stake
It was revealed in a filing yesterday with the U.S Securities and Exchange Commission that RA Capital Management has opened a large, passive position......(read more)
Bellicum Pharmaceuticals Inc (BLCM): Baker Bros. Discloses 16% Passive Stake
As a new filing with the Securities and Exchange Commission showed, Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) has been added to the equity portfolio......(read more)
Vanda Pharmaceuticals Inc (VNDA): Deerfield Management Increases Exposure Following Positive Announcement
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday. After adding more than 1......(read more)
Seattle Genetics Inc. (SGEN), Cerus Corporation (CERS): Baker Bros. Advisors’ Latest Moves
Baker Bros. Advisors, the fund managed by Julian and Felix Baker disclosed changes in two of its activist positions last Thursday. The firm continued......(read more)
